• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

The Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular Complications

SWAlexander

SWAlexander

Senior Member
Messages
1,942
wastwater said:
https://www.frontiersin.org/articles/10.3389/fcvm.2021.681948/full
The Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular Complications
Click to expand...

This is the most important part and most overlooked by doctors since publication in May:
"The Coagulopathic Response
The realization that COVID-19 causes hypercoagulopathy poses more questions than answers, with studies showing severe thrombotic manifestations, while others show postmortem lung sections with extensive bleeding (117, 118). In a recent study by Boonyawa et al. a 28% incidence of venous thromboembolism was reported in COVID-19 patients in the intensive care unit (119). Another study by Klok et al. found a 31% incidence of combined deep vein thrombosis, pulmonary embolism, and arterial thrombosis in critically ill patients (120). Thus, there is an urgent need to understand the rate of bleeding and thrombotic events associated with COVID-19 coagulopathy."
more at: https://www.openaccessgovernment.org/blood-clots-long-covid/121511/
 
Last edited:
You must log in or register to reply here.